Neurobiology of Aging
Volume 29, Issue 7 , Pages 1052-1059 , July 2008

Reversion of age-related recognition memory impairment by iron chelation in rats

  • Maria Noêmia Martins de Lima

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Biomedical Gerontology, Institute for Geriatrics and Gerontology, São Lucas Hospital, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Caroline Pietá Dias

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Biomedical Gerontology, Institute for Geriatrics and Gerontology, São Lucas Hospital, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Juliana Presti Torres

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Cellular and Molecular Biology, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Arethuza Dornelles

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Cellular and Molecular Biology, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Vanessa Athaíde Garcia

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Felipe Siciliani Scalco

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Marcelo Rewsaat Guimarães

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Roberta Cristina Petry

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Elke Bromberg

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Biomedical Gerontology, Institute for Geriatrics and Gerontology, São Lucas Hospital, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • ,
  • Larissa Constantino

      Affiliations

    • Physiopathology Laboratory, Department of Medicine, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
    • ,
  • Patricia Budni

      Affiliations

    • Physiopathology Laboratory, Department of Medicine, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
    • ,
  • Felipe Dal-Pizzol

      Affiliations

    • Physiopathology Laboratory, Department of Medicine, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
    • ,
  • Nadja Schröder

      Affiliations

    • Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Biomedical Gerontology, Institute for Geriatrics and Gerontology, São Lucas Hospital, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Graduate Program in Cellular and Molecular Biology, Faculty of Biosciences, Pontifical Catholic University, 90619-900 Porto Alegre, RS, Brazil
    • Corresponding Author InformationCorresponding author at: Department of Physiological Sciences, Faculty of Biosciences, Pontifical Catholic University, Av. Ipiranga, 6681 Prédio 12C, Sala 266, 90619-900 Porto Alegre, RS, Brazil. Tel.: +55 51 33203545; fax: +55 51 33203612.

Received 21 October 2006 ,Revised 26 December 2006 ,Accepted 5 February 2007.

References 

  1. Abd El Mohsen MM, Iravani MM, Spencer JP, Rose S, Fahim AT, Motawi TM, et al. Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants. Biochem. Biophys. Res. Commun. 2005;336(2):386–391
  2. Anderson GJ, Powell LW. Of metals, mice, and men: what animal models can teach us about body iron loading. J. Clin. Invest. 2000;105(9):1185–1186
  3. Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol. Biol. (Noisy-le-grand). 2000;46(4):821–833
  4. Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J. Increased basal ganglia iron levels in Huntington disease. Arch. Neurol. 1999;56(5):569–574
  5. Benkovic SA, Connor JR. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. Comp. Neurol. 1993;338:97–113
  6. Ben-Shachar D, Eshel G, Finberg JP, Youdim MB. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 1991;56(4):1441–1444
  7. Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J. Pharmacol. Toxicol. Methods. 2006;54(2):99–105
  8. Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA. Iron: a pathological mediator of Alzheimer disease?. Dev. Neurosci. 2002;24:184–187
  9. Cini M, Moretti A. Studies on lipid peroxidation and protein oxidation in the aging brain. Neurobiol. Aging. 1995;16(1):53–57
  10. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt PA. A quantitative analysis of isoferritins in select regions of the aged, parkinsonian and Alzheimer Disease brains. J. Neurochem. 1995;65:717–724
  11. Crapper DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet. 1991;338(8762):324–326
  12. Dal-Pizzol F, Klamt F, Frota MLC, Andrades ME, Caregnato FF, Vianna MRM, et al. Neonatal iron exposure induces oxidative stress in adult Wistar rats. Dev. Brain Res. 2001;130:109–114
  13. De Lima MN, Luft T, Roesler R, Schröder N. Temporary inactivation reveals an essential role of the dorsal hippocampus in consolidation of object recognition memory. Neurosci. Lett. 2006;405(1–2):142–146
  14. De Lima MN, Polydoro M, Laranja DC, Bonatto F, Bromberg E, Moreira JC, et al. Recognition memory impairment and brain oxidative stress induced by postnatal iron administration. Eur. J. Neurosci. 2005;21(9):2521–2528
  15. De Lima MN, Laranja DC, Caldana F, Grazziotin MM, Garcia VA, Dal-Pizzol F, et al. Selegiline protects against recognition memory impairment induced by neonatal iron treatment. Exp. Neurol. 2005;196(1):177–183
  16. De Lima MN, Laranja DC, Caldana F, Bromberg E, Roesler R, Schröder N. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp. Gerontol. 2005;40(6):506–511
  17. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, et al. Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 1994;52:1830–1836
  18. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 1991;114(Pt 4):1953–1975
  19. Dix SL, Aggleton JP. Extending the spontaneous preference test of recognition: evidence of object-location and object-location and object-context recognition. Behav. Brain Res. 1999;99:191–200
  20. Ebaldi M, Srinivasan SK, Baxi MD. Oxidative stress and oxidant therapy in Parkinson's disease. Prog. Neurobiol. 1996;48:1–19
  21. Ennanceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. I. Behavioral data. Behav. Brain Res. 1988;31:47–59
  22. Finefrock AE, Bush AI, Doraiswamy PM. Current status of metals as therapeutic targets in Alzheimer's disease. J. Am. Geriatr. Soc. 2003;51:1143–1148
  23. Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol. Appl. Pharmacol. 1999;159:25–30
  24. Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Dev. Brain Res. 2000;119:65–74
  25. Freret T, Valable S, Chazalviel L, Saulnier R, Mackenzie ET, Petit E, et al. Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur. J. Neurosci. 2006;23(7):1757–1765
  26. Friguet B. Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett. 2006;580:2910–2916
  27. Grabill C, Silva AC, Smith SS, Koretsky AP, Rouault TA. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res. 2003;971(1):95–106
  28. Grifiths PD, Dobson BR, Jones GR, Clarke DT. Iron in the basal ganglia in Parkinson's disease. An in vivo study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain. 1999;122(4):667–673
  29. Hallgren B, Sourander P. The effect of aging on the non-haemin iron in the human brain. J. Neurochem. 1958;3:41–51
  30. House MJ, St. Pierre TG, Foster JK, Martins RN, Clarnette R. Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. Am. J. Neuroradiol. 2006;27(2):430–439
  31. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron. 2003;37(6):899–909
  32. Kienzl E, Puchinger L, Jellinger K, Linert W, Stachellberger H, Jameson RF. The role of transition metals in the pathogenesis of Parkinson's disease. J. Neurol. Sci. 1995;134:69–78
  33. Kolosova NG, Shcheglova TV, Sergeeva SV, Loskutova LV. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol. Aging. 2006;27(9):1289–1297
  34. Lan J, Jiang DH. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transm. 1997;104:469–481
  35. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–478
  36. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. U.S.A. 2003;100:8526–8531
  37. Long DA, Ghosh K, Moore AN, Dixon CE, Dash PK. Deferoxamine improves spatial memory performance following experimental brain injury in rats. Brain Res. 1996;717(1–2):109–117
  38. Lowry OH, Rosebrough AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951;193:265–275
  39. Lynch T, Cherny R, Bush AI. Oxidative processes in Alzheimer's disease: the role of Abeta–metal interactions. Exp. Gerontol. 2000;35:445–451
  40. Martin I, Grotewiel MS. Oxidative damage and age-related functional declines. Mech. Ageing Dev. 2006;127:411–423
  41. Martin WR, Ye FQ, Allen PS. Increasing striatal iron content associated with normal aging. Mov. Disord. 1998;13:281–286
  42. Martinez M, Hernandez AI, Martinez N. N-Acetylcysteine delays age-associated memory impairment in mice: role in synaptic mitochondria. Brain Res. 2000;855(1):100–106
  43. Mooradian AD. Effect of aging on the blood–brain barrier. Neurobiol. Aging. 1988;9(1):31–39
  44. Moses SN, Cole C, Driscoll I, Ryan JD. Differential contributions of hippocampus, amygdala and perirhinal cortex to recognition of novel objects, contextual stimuli and stimulus relationships. Brain Res. Bull. 2005;67(1–2):62–76
  45. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn. Mem. 2002;9(2):49–57
  46. Mumby DG. Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats. Behav. Brain Res. 2001;127:159–181
  47. Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K, et al. Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience. 2001;107(3):415–431
  48. Ong WY, Farooqui AA. Iron, neuroinflammation, and Alzheimer's disease. J. Alzheimers Dis. 2005;8(2):183–200(discussion 209–15)
  49. Park MJ, Lee SK, Lim MA, Chung HS, Cho SI, Jang CG, et al. Effect of alpha-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity. Brain Res. 2006;1109(1):176–182
  50. Polla AS, Polla LL, Polla BS. Iron as the malignant spirit in successful ageing. Ageing Res. Rev. 2003;2:25–37
  51. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 2002;59(6):972–976
  52. Qian ZM, Shen X. Brain iron transport and neurodegeneration. Trends Mol. Med. 2001;7(3):103–108
  53. Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, et al. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 2006;153(1):42–54
  54. Rampon C, Tang YP, Goodhouse J, Shimizu E, Kyin M, Tsien JZ. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat. Neurosci. 2000;3(3):238–244
  55. Regland B, Lehmann W, Abedini I, Blennow K, Jonsson M, Karlsson I, et al. Treatment of Alzheimer's disease with clioquinol. Dement. Geriatr. Cogn. Disord. 2001;12(6):408–414
  56. Richardson DR. Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann. NY Acad. Sci. 2004;1012:326–341
  57. Riederer P, Sofic E, Rausch WD, Schmidt D, Reynolds GP, Jellinger K, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 1989;52:515–520
  58. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 2003;60(12):1685–1691
  59. Schipper HM. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res. Rev. 2004;3:265–301
  60. Schröder N, Fredriksson A, Vianna MRM, Roesler R, Izquierdo I, Archer T. Memory deficits in adult rats following postnatal iron administration. Behav. Brain. Res. 2001;124:77–85
  61. Schröder N, O’Dell SJ, Marshall JF. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse. 2003;49:89–96
  62. Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lesion in rats. Neuropharmacology. 2004;46(2):254–263
  63. Shah GN, Mooradian AD. Age-related changes in the blood–brain barrier. Exp. Gerontol. 1997;32(4–5):501–519
  64. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr. Opin. Neurol. 2004;17(4):437–442
  65. Topic B, Tani E, Tsiakitzis K, Kourounakis PN, Dere E, Hasenohrl RU, et al. Enhanced maze performance and reduced oxidative stress by combined extracts of zingiber officinale and ginkgo biloba in the aged rat. Neurobiol. Aging. 2002;23(1):135–143
  66. Wais PE, Wixted JT, Hopkins RO, Squire LR. The hippocampus supports both the recollection and the familiarity components of recognition memory. Neuron. 2006;49(3):459–466
  67. Wan S, Hua Y, Keep RF, Hoff JT, Xi G. Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. Acta Neurochir. Suppl. 2006;96:199–202
  68. Ward RJ, Dexter D, Florence A, Aouad F, Hider R, Jenner P, et al. Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism. Biochem. Pharmacol. 1995;49:1821–1826
  69. Youdim MB, Stephenson G, Ben Shachar D. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann. NY Acad. Sci. 2004;1012:306–325
  70. Zecca L, Gallorini M, Schünemann V, Trautwein AX, Gerlach A, Riederer P, et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 2001;76:1766–1773
  71. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004;5(11):863–873
  72. Zhang P, Land W, Lee S, Juliani J, Lefman J, Smith SR, et al. Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J. Struct. Biol. 2005;150(2):144–153
  73. Zhang X, Xie W, Qu S, Pan T, Wang X, Le W. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. Biochem. Biophys. Res. Commun. 2005;333(2):544–549

PII: S0197-4580(07)00048-6

doi: 10.1016/j.neurobiolaging.2007.02.006

Neurobiology of Aging
Volume 29, Issue 7 , Pages 1052-1059 , July 2008

Article Tools

* Image Usage & Resolution